Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€5.92
15.09.20
€3.00
30.09.20
72.89%
30.09.20

Could be worthwhile Investment >10% per year
buy
Shell plc

Start price
Target price
Perf. (%)
€11.72
14.09.20
€21.00
04.11.21
46.82%
02.08.21

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€57.26
14.09.20
€78.00
16.10.20
39.19%
16.10.20

Could be very worthwhile Investment >20% year
buy
Hewlett Packard Enterprise Co

Start price
Target price
Perf. (%)
€7.96
14.09.20
-
04.11.21
11.01%
19.11.20

Top 10 in its market
Well known brand
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€95.98
14.09.20
-
04.11.21
37.03%
05.11.21

Could be very worthwhile Investment >20% year
buy
PIMCO Dynamic Credit Income Fund

Start price
Target price
Perf. (%)
€20.32
13.09.20
€22.97
24.10.24
-14.99%
13.06.22

buy
Paragon AG

Start price
Target price
Perf. (%)
€9.89
12.09.20
-
04.11.21
-4.95%
16.11.20

Capable Management
Revenue growth >5% per year expected
buy
MTU Aero Engines AG

Start price
Target price
Perf. (%)
€157.65
12.09.20
-
04.11.21
23.22%
14.11.20

Good rating
positive Cash Flow expected
Revenue growth >5% per year expected
Normal challenges to pay loans and raise capital
Verisign Inc.

Start price
Target price
Perf. (%)
€169.72
11.09.20
-
04.11.21
-1.60%
25.11.20

Probably not worthwhile Investment
Revenue decline/stagnation expected
Very low/no dividend yield expected
Chevron Corp.

Start price
Target price
Perf. (%)
€65.63
11.09.20
€55.00
05.10.20
-7.02%
05.10.20

BASF SE

Start price
Target price
Perf. (%)
€54.97
11.09.20
-
04.11.21
0.80%
12.11.20

Increased challenges to pay loans and raise capital
Higher risks for its business
Low dividend yield expected
buy
Bolloré S.A.

Start price
Target price
Perf. (%)
€3.24
11.09.20
€4.50
04.11.21
56.44%
05.11.21

Could be worthwhile Investment >10% per year
buy
Novozymes A/S B

Start price
Target price
Perf. (%)
€55.52
11.09.20
€63.00
04.11.21
18.70%
05.11.21

Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
Revenue decline/stagnation expected
buy
Samsung SDI Co. Ltd. GDR

Start price
Target price
Perf. (%)
€77.40
11.09.20
-
04.11.21
32.43%
22.11.20

Future proof or reliable business model
Market Leader or Top 3
Innovative
Well known brand
Satsuma Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.30
11.09.20
€2.00
04.11.21
16.74%
17.06.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Walter Bau-AG ST

Start price
Target price
Perf. (%)
€0.001
11.09.20
€0.002
24.09.20
300.00%
24.09.20

Undervalued
Risky Investment
High risks for its business
No Innovation
Kelly Services Inc. A

Start price
Target price
Perf. (%)
€14.30
10.09.20
-
15.09.20
-2.10%
15.09.20

Risky Investment
Geely Automobile Holdings

Start price
Target price
Perf. (%)
€1.72
10.09.20
-
04.11.21
32.36%
16.11.20

Some uniques
Below average Management
Business model of the past or high risk
buy
Satsuma Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.60
10.09.20
-
19.09.20
-32.50%
19.09.20

Good culture
Could be very worthwhile Investment >20% year
Capable Management
Few uniques
News Corp. B

Start price
Target price
Perf. (%)
€12.60
10.09.20
-
04.11.21
18.25%
20.11.20

Low dividend yield expected
Revenue decline/stagnation expected
negative Cash Flow expected
Few uniques
Reconnaissance Energy Afri.ltd

Start price
Target price
Perf. (%)
€0.72
10.09.20
-
04.11.21
477.08%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Quantafuel ASA

Start price
Target price
Perf. (%)
€8.14
10.09.20
-
04.11.21
-69.26%
05.11.21

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
High valuation
buy
Amira Nature Food Ltd.

Start price
Target price
Perf. (%)
€1.58
10.09.20
-
04.11.21
463.29%
05.11.21

Fair valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€48.40
10.09.20
-
04.11.21
-26.12%
05.11.21

Revenue growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Increased challenges to pay loans and raise capital
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€52.11
09.09.20
€85.00
19.10.20
58.30%
19.10.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very Future proof/growth oriented business model
Capable Management